Oxygenta Pharmaceutical Ltd Share Price Live
Live Oxygenta Pharmaceutical Share Price Chart
Oxygenta Pharmaceutical Performance
Days Range
| Previous Close | ₹62.74 |
|---|---|
| Open | ₹61.5 |
| Volume | 12,616 |
| Day's Range | ₹59.70 - ₹63.30 |
|---|---|
| 52W Range | ₹53.56 - ₹133.50 |
| Market Cap | ₹232.03 Cr |
Oxygenta Pharmaceutical Fundamentals
| ROCE(TTM) | -53.26 |
|---|---|
| P/E Ratio (TTM) | -13.55 |
| P/B Ratio | 0 |
| Industry P/E | 40.32 |
| Debt to Equity | -1.99 |
| ROE | 46.67 |
| EPS (TTM) | 0 |
| Dividend Yield | 0 |
| Book Value | -9.92 |
| Face Value | 10 |
| ROCE(TTM) | -53.26 |
|---|---|
| P/E Ratio (TTM) | -13.55 |
| P/B Ratio | 0 |
| Industry P/E | 40.32 |
| Debt to Equity | -1.99 |
| ROE | 46.67 |
|---|---|
| EPS (TTM) | 0 |
| Dividend Yield | 0 |
| Book Value | -9.92 |
| Face Value | 10 |
Oxygenta Pharmaceutical Financials
| Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | |
|---|---|---|---|---|
| Net Sales | 33.21 | 49.47 | 15.13 | 14.30 |
| Expenses | 38.27 | 50.92 | 22.81 | 19.73 |
| Profit before tax | -4.96 | -3.80 | -8.15 | -6.44 |
| Operating Profit | -3.93 | -2.15 | -6.11 | -4.93 |
| Net Profit | -3.93 | -2.15 | -6.11 | -4.93 |
| ESP in Rs | 1.07 | -0.52 | -1.65 | -1.33 |
Oxygenta Pharmaceutical Shareholding Pattern
| Held by | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|
| Promoters | 53.28% | 51.12% | 51.12% | 57.92% | 57.95% |
| Flls | 0% | 0% | 0% | 0% | 0% |
| Dlls | 0.03% | 0.03% | 0.03% | 0.03% | 0.03% |
| Public | 46.69% | 48.85% | 48.85% | 42.06% | 42.02% |
About Oxygenta Pharmaceutical
S S Organics Ltd is engaged in manufacture of bulk drugs. The company manufactures a wide range of new generation quinolones, antiasthmatic, antiulcerant, and anti-inflammatory drugs. The company has its plant located at Medak in Andhra Pradesh. The company was incorporated in the year 1990 as a private limited company, and was later converted into a public limited company in the year 1993.
Parent Organisation
Indian Private
Managing Director
None
Founded
1990
NSE Symbol
Top Mutual Funds Invested in Oxygenta Pharmaceutical Share
Top Mutual Funds Invested in Oxygenta Pharmaceutical Share
| FUND NAME | AUM(%) |
|---|---|
Peer Comparison
Peer Comparison
| Stocks | LTP (₹) | Market Cap (cr) | 52 Week Low-High (₹) |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd | 1,831.1 20.80 (1.15%) | ₹4,34,159.66 | 1,548.0 - 1,910.0 |
| Divis Laboratories Ltd | 6,471.0 -19.50 (-0.30%) | ₹1,72,287.78 | 4,955.0 - 7,071.5 |
| Torrent Pharmaceuticals Ltd | 3,722.0 -8.40 (-0.23%) | ₹1,26,434.15 | 2,886.45 - 3,882.2 |
| Cipla Ltd | 1,530.9 5.70 (0.37%) | ₹1,23,148.76 | 1,335.0 - 1,673.0 |
| Dr Reddys Laboratories Ltd | 1,257.1 7.80 (0.62%) | ₹1,04,369.38 | 1,020.0 - 1,405.9 |
| Lupin Ltd | 2,085.1 13.70 (0.66%) | ₹94,659.39 | 1,795.2 - 2,402.9 |
Popular stocks
Oxygenta Pharmaceutical Ltd FAQs
What is the share price of Oxygenta Pharmaceutical Ltd (Oxygenta Pharmaceutical Ltd) shares?
Oxygenta Pharmaceutical Ltd (Oxygenta Pharmaceutical Ltd) share price as of November 28, 2025, on NSE is Rs 59.61 (NSE) and Rs 59.61 (BSE) on BSE.
Can I buy Oxygenta Pharmaceutical Ltd (Oxygenta Pharmaceutical Ltd) from Angel One?
Yes, You can buy Oxygenta Pharmaceutical Ltd (Oxygenta Pharmaceutical Ltd) shares by opening a Demat account with Angel One.
How do I buy Oxygenta Pharmaceutical Ltd (Oxygenta Pharmaceutical Ltd) from Angel One?
Oxygenta Pharmaceutical Ltd (Oxygenta Pharmaceutical Ltd) share can be bought through the following modes:
1. Direct investment: You can buy Oxygenta Pharmaceutical Ltd (Oxygenta Pharmaceutical Ltd) shares by opening a Demat account with Angel One.
2. Indirect investment: The indirect method involves investing through ETFs and Mutual Funds that offer exposure to Oxygenta Pharmaceutical Ltd (Oxygenta Pharmaceutical Ltd) shares.
1. Direct investment: You can buy Oxygenta Pharmaceutical Ltd (Oxygenta Pharmaceutical Ltd) shares by opening a Demat account with Angel One.
2. Indirect investment: The indirect method involves investing through ETFs and Mutual Funds that offer exposure to Oxygenta Pharmaceutical Ltd (Oxygenta Pharmaceutical Ltd) shares.
